| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $971,664 ) |
| 2024 | 2024 | BIOPEPTIDES CORP | 36 TOPSTONE RD | RIDGEFIELD | CT | 06877-3411 | WESTERN CT | USA | R44AI184034 | A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease. | 000 | 1 | NIH | 6/28/2024 | $971,664 |
|
 | Issue Date FY: 2023 ( Subtotal = $971,240 ) |
| 2023 | 2023 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 000 | 4 | NIH | 7/5/2023 | $971,240 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,051,864 ) |
| 2022 | 2022 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 002 | 3 | NIH | 9/6/2022 | $65,384 |
| 2022 | 2022 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 001 | 3 | NIH | 6/27/2022 | $986,480 |
| 2022 | 2020 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R43AI142877 | An antigen-capture assay to screen donated blood for Babesia microti | 000 | 2 | NIH | 4/6/2022 | $0 |
| 2022 | 2020 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 000 | 1 | NIH | 2/7/2022 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $1,000,000 ) |
| 2021 | 2021 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 000 | 2 | NIH | 7/16/2021 | $1,000,000 |
|
 | Issue Date FY: 2020 ( Subtotal = $599,812 ) |
| 2020 | 2020 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI150060 | A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease | 000 | 1 | NIH | 6/24/2020 | $300,000 |
| 2020 | 2020 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R43AI142877 | An antigen-capture assay to screen donated blood for Babesia microti | 000 | 2 | NIH | 2/4/2020 | $299,812 |
|
 | Issue Date FY: 2019 ( Subtotal = $299,812 ) |
| 2019 | 2019 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R43AI142877 | An antigen-capture assay to screen donated blood for Babesia microti | 000 | 1 | NIH | 3/14/2019 | $299,812 |
| 2019 | 2017 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI102435 | Development of a cytokine release assay for the diagnosis of Lyme disease | 000 | 4 | NIH | 8/28/2019 | $0 |
|
 | Issue Date FY: 2017 ( Subtotal = $605,367 ) |
| 2017 | 2017 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R44AI102435 | Development of a cytokine release assay for the diagnosis of Lyme disease | 000 | 4 | NIH | 5/15/2017 | $605,367 |
| 2017 | 2016 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R43AI122399 | Peptide-based Multiplex Assay for Lyme disease Serodiagnosis | 000 | 1 | NIH | 4/4/2017 | $0 |
| 2017 | 2016 | BIOPEPTIDES CORP | 18 WOODHULL RD | EAST SETAUKET | NY | 11733-3728 | SUFFOLK | USA | R43AI120364 | A Rapid Point-of-Care Assay for the Diagnosis of Lyme Disease | 000 | 1 | NIH | 8/17/2017 | $0 |
|
 | Issue Date FY: 2016 ( Subtotal = $933,425 ) |
| 2016 | 2016 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI120364 | A Rapid Point-of-Care Assay for the Diagnosis of Lyme Disease | 000 | 1 | NIH | 6/9/2016 | $151,776 |
| 2016 | 2016 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI122399 | Peptide-based Multiplex Assay for Lyme disease Serodiagnosis | 000 | 1 | NIH | 12/30/2015 | $176,282 |
| 2016 | 2016 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R44AI102435 | Development of a cytokine release assay for the diagnosis of Lyme disease | 000 | 3 | NIH | 6/15/2016 | $605,367 |
| 2016 | 2015 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R41AI108006 | Development of an Antigen Capture Assay for Babesia microti | 000 | 2 | NIH | 6/8/2016 | $0 |
|
 | Issue Date FY: 2015 ( Subtotal = $286,079 ) |
| 2015 | 2015 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R41AI108006 | Development of an Antigen Capture Assay for Babesia microti | 000 | 2 | NIH | 5/8/2015 | $286,079 |
|
 | Issue Date FY: 2014 ( Subtotal = $300,000 ) |
| 2014 | 2014 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R41AI108006 | Development of an Antigen Capture Assay for Babesia microti | 000 | 1 | NIH | 6/11/2014 | $300,000 |
|
 | Issue Date FY: 2013 ( Subtotal = $300,000 ) |
| 2013 | 2013 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI102435 | DEVELOPMENT OF A CYTOKINE RELEASE ASSAY AS A DIAGNOSTIC TEST FOR LYME DISEASE | 000 | 2 | NIH | 6/7/2013 | $300,000 |
| 2013 | 2012 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI096551 | LAB ON A CHIP POINT OF CARE ASSAY FOR THE RAPID SERODIAGNOSIS OF LYME DISEASE | 000 | 2 | NIH | 9/19/2013 | $0 |
|
 | Issue Date FY: 2012 ( Subtotal = $600,000 ) |
| 2012 | 2012 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI102435 | DEVELOPMENT OF A CYTOKINE RELEASE ASSAY AS A DIAGNOSTIC TEST FOR LYME DISEASE | 000 | 1 | NIH | 6/13/2012 | $300,000 |
| 2012 | 2012 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI096551 | LAB ON A CHIP POINT OF CARE ASSAY FOR THE RAPID SERODIAGNOSIS OF LYME DISEASE | 000 | 2 | NIH | 8/2/2012 | $300,000 |
|
 | Issue Date FY: 2011 ( Subtotal = $1,019,308 ) |
| 2011 | 2011 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI096551 | LAB ON A CHIP POINT OF CARE ASSAY FOR THE RAPID SERODIAGNOSIS OF LYME DISEASE | 000 | 1 | NIH | 9/6/2011 | $300,000 |
| 2011 | 2011 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI096551 | LAB ON A CHIP POINT OF CARE ASSAY FOR THE RAPID SERODIAGNOSIS OF LYME DISEASE | 001 | 1 | NIH | 9/19/2011 | $300,000 |
| 2011 | 2011 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI096551 | LAB ON A CHIP POINT OF CARE ASSAY FOR THE RAPID SERODIAGNOSIS OF LYME DISEASE | 001 | 1 | NIH | 9/19/2011 | -$300,000 |
| 2011 | 2011 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R44AI074092 | MULTI-ANTIGEN PEPTIDE ASSAY FOR THE SERODIAGNOSIS OF LYME DISEASE | 000 | 5 | NIH | 7/27/2011 | $719,308 |
|
 | Issue Date FY: 2010 ( Subtotal = $727,043 ) |
| 2010 | 2010 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R44AI074092 | MULTI-ANTIGEN PEPTIDE ASSAY FOR THE SERODIAGNOSIS OF LYME DISEASE | 001 | 4 | NIH | 7/28/2010 | $727,043 |
| 2010 | 2009 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R44AI074092 | MULTI-ANTIGEN PEPTIDE ASSAY FOR THE SERODIAGNOSIS OF LYME DISEASE | 000 | 3 | NIH | 6/25/2010 | $0 |
|
 | Issue Date FY: 2009 ( Subtotal = $583,580 ) |
| 2009 | 2009 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R44AI074092 | MULTI-ANTIGEN PEPTIDE ASSAY FOR THE SERODIAGNOSIS OF LYME DISEASE | 000 | 3 | NIH | 8/6/2009 | $583,580 |
|
 | Issue Date FY: 2008 ( Subtotal = $599,568 ) |
| 2008 | 2008 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI072810 | BAIT VACCINE AGAINST LYME BORRELIOSIS | 000 | 2 | NIH | 9/3/2008 | $299,997 |
| 2008 | 2008 | BIOPEPTIDES INC | 25 EAST LOOP ROAD | STONY BROOK | NY | 11790 | SUFFOLK | USA | R43AI074092 | MULTI-PEPTIDE ASSAY FOR SERODIAGNOSIS OF LYME DISEASE | 000 | 2 | NIH | 6/23/2008 | $299,571 |
|
 | Issue Date FY: 2007 ( Subtotal = $599,567 ) (Continued on the next page) |
|